Business context and reporting period
This filing is ESGEN Acquisition Corporation’s unaudited Form 10-Q for the quarter ended March 31, 2022—not a filing by Zeo Energy Corp. ESGEN was a SPAC searching for a business-combination target and had not selected one. It had no operating revenue or business operations during the quarter.
Key financial metrics
- Quarter results: Net income was $5.88 million, or $0.17 per Class A and Class B share. The result included $6.74 million of income from a decrease in the fair value of warrant liabilities and $18,171 of trust-account interest, offset by $872,990 of operating costs. The filing reports no revenue.
- Cash flow: Cash used in operating activities was $237,819. Cash declined from $1.32 million at December 31, 2021 to $1.09 million at March 31, 2022.
- Liquidity and assets: Working capital was approximately $420,473. Total assets were $283.11 million, including $281.54 million of marketable securities in the trust account.
- Liabilities and equity: Total liabilities were $18.05 million, including $7.24 million of warrant liabilities and $9.66 million of deferred underwriting discount. The $281.54 million of redeemable Class A shares was classified as temporary equity; shareholders’ deficit was $16.48 million. The company reported $171,346 outstanding under a related-party promissory note and no working-capital loans.
Material changes and comparison
The filing does not provide a prior-year comparable-quarter income statement or cash-flow period. Compared with December 31, 2021, cash fell by about $238,000, warrant liabilities declined from $13.98 million to $7.24 million, and the accumulated deficit narrowed from $22.34 million to $16.48 million, principally reflecting the quarter’s reported net income. That income was driven mainly by the noncash warrant fair-value change, not operating activity.
Outlook, risks and unusual items
- The company had no target and would not generate operating revenue until after a business combination. It generally had 15 months from the October 22, 2021 IPO closing to complete a combination, subject to possible extensions described in the filing; otherwise, public shares would be redeemed and the company would wind up.
- The filing states that cash outside the trust was not expected to fund at least 12 months of operations absent a combination, raising substantial doubt about the company’s ability to continue as a going concern. Management expected a combination and possible sponsor or insider loans to address funding needs, but such loans were not committed. The filing also says management believed available working capital and borrowing capacity would meet needs through the earlier of a combination or one year from the filing; these statements are conditional and do not eliminate the disclosed uncertainty.
- A material weakness in internal control over financial reporting—insufficient qualified accounting resources, including errors in earnings-per-share allocation—remained. Management described remediation efforts but gave no assurance they would be effective.
- The company reported no material COVID-19 impact to date, while noting that broader effects were uncertain. It reported no legal proceedings and no material changes to previously disclosed risk factors.
- The $9.66 million deferred underwriting discount is payable upon completion of a business combination. Warrant fair values rely in part on valuation assumptions, including Level 3 inputs for private warrants, and changes affect reported earnings.
Important facts to verify
- Confirm the filing entity: this 10-Q is for ESGEN Acquisition Corporation, despite the request metadata naming Zeo Energy Corp.
- Check subsequent filings for a target, business-combination progress, deadline extensions, or additional financing.
- Assess cash needs outside the trust, the going-concern disclosure, and whether sponsor or insider funding is actually available.
- Review remediation of the disclosed material weakness and the accounting treatment and valuation of warrants.